Arteriotomy Closure Devices Market Demonstrates Long-Term Growth Potential At 6.7% CAGR

The arteriotomy closure devices market is on the path to significant growth, driven by advances in vascular closure technologies and increasing demand for safer, minimally invasive procedures. As healthcare providers seek more effective methods to manage vascular access sites, this market is expected to expand steadily over the coming years. Let's explore the market's projected size, key players, emerging trends, and the main segments shaping its future.

Projected Market Value and Growth of the Arteriotomy Closure Devices Market
The arteriotomy closure devices market is projected to reach a valuation of $2.38 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.7%. This upward trend is fueled by factors such as the rising demand for advanced vascular closure solutions, increased attention to minimizing procedural complications, a surge in outpatient vascular procedures, growing investments in bioresorbable materials, and wider adoption of cutting-edge closure technologies. Among the key developments anticipated are a stronger inclination toward suture-based closure solutions, a preference for radial access closure devices, expanded use of bioabsorbable hemostatic materials, and a growing emphasis on minimally invasive vascular interventions that promote quicker patient recovery.

Download a free sample of the arteriotomy closure devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Companies Driving Innovation in the Arteriotomy Closure Devices Industry
Several major corporations lead the arteriotomy closure devices market, including Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., and Vivasure Medical.
In a notable industry partnership, January 2025 saw Greece-based medical device distributor Kalteq Group form an exclusive agreement with Teleflex. Through this collaboration, Kalteq Group will distribute the MANTA Vascular Closure Device across Greece, broadening access to innovative large-bore femoral arterial closure solutions known to enhance procedural efficiency and patient outcomes. Teleflex, Inc., headquartered in the United States, specializes in producing arteriotomy closure devices.

Emerging Trends Shaping the Arteriotomy Closure Devices Market
Innovation is at the forefront of this market as companies focus on developing products that improve procedural efficiency and patient outcomes while addressing the growing demand for minimally invasive vascular access solutions.
An example of such innovation is the development of mid-bore venous closure devices, which are designed to seal venous access points created by medium-sized catheters or sheaths, facilitating hemostasis and aiding quicker patient recovery post-procedure. Illustrating this trend, in June 2024, US-based Haemonetics Corporation expanded its VASCADE product line by introducing the VASCADE MVP XL mid-bore venous closure device. This device accommodates larger sheaths (10-12F, up to 15F outer diameter) used in procedures like cryoablation and features 58% more collagen alongside a larger collapsible disc for faster hemostasis. This release complements Haemonetics' existing portfolio of small- and mid-bore vascular closure devices, underscoring the company's leadership in advanced closure technologies.

View the full arteriotomy closure devices market report:
https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Main Segments Analyzed in the Arteriotomy Closure Devices Market
This market report categorizes the arteriotomy closure devices industry into several distinct segments:
1) Product Type: Active Closure Devices and Passive Closure Devices
2) Application: Femoral Arterial Access Procedures and Radial Arterial Access Procedures
3) End User: Hospitals, Ambulatory Care Centers, and Other End Users
Further breakdowns of these segments include:
- Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices with Collagen or Hemostatic Agents, and Balloon-Based Devices
- Passive Closure Devices: Compression Devices, Hemostatic Patches or Sponges, and Vascular Plugs or Plugs

By understanding these categories, stakeholders can better navigate the market landscape and identify opportunities for growth and innovation.

What's new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.